Literature DB >> 15722580

Misinterpretation of osteodensitometry with high bone density: BMD Z > or = + 2.5 is not "normal".

Michael P Whyte1.   

Abstract

Osteodensitometry is increasingly used to identify low bone density resulting from osteoporosis. The universally accepted World Health Organization (WHO) criteria for assessing bone mineral density (BMD) contrasts individual T-scores to peak BMD in healthy adult control populations. In this scheme, "osteoporosis" refers arbitrarily to T-values below -2.5, "osteopenia" to values between -1.0 and -2.5, and "normal" to values above -1.0. Although individually rare, numerous conditions cause supranormal BMD in children and adults. Increasingly, elevated BMD is detected by osteodensitometry, especially dual-energy X-ray absorptiometry. Illustrated here, the absence of upper limits for BMD in the WHO criteria jeopardizes recognition of high-BMD disease for all age groups. This oversight requires correction using Z-scores.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15722580     DOI: 10.1385/jcd:8:1:001

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.963


  12 in total

1.  High bone mineral density is associated with high body mass index.

Authors:  S Morin; W D Leslie
Journal:  Osteoporos Int       Date:  2008-11-26       Impact factor: 4.507

Review 2.  Elevated bone mass: a weighty matter?

Authors:  William D Leslie
Journal:  Skeletal Radiol       Date:  2008-12       Impact factor: 2.199

3.  Discrepancy between bone density and bone material strength index in three siblings with Camurati-Engelmann disease.

Authors:  S Herrera; R Soriano; X Nogués; R Güerri-Fernandez; D Grinberg; N García-Giralt; N Martínez-Gil; S Castejón; A González-Lizarán; S Balcells; A Diez-Perez
Journal:  Osteoporos Int       Date:  2017-08-25       Impact factor: 4.507

4.  The assessment of bone mineral content and density of the lumbar spine and proximal femur in US submariners.

Authors:  H G Gasier; L M Hughes; C R Young; A M Richardson; A R Richardson
Journal:  Osteoporos Int       Date:  2014-05-28       Impact factor: 4.507

5.  Normal bone density and trabecular bone score, but high serum sclerostin in congenital generalized lipodystrophy.

Authors:  Josivan Gomes Lima; Lucia Helena C Nobrega; Natalia Nobrega Lima; Marcel Catão Ferreira Dos Santos; Maria de Fatima P Baracho; Renaud Winzenrieth; Francisco Bandeira; Carolina de O Mendes-Aguiar; Francisco Paulo Freire Neto; Leonardo Capistrano Ferreira; Clifford J Rosen; Selma Maria B Jeronimo
Journal:  Bone       Date:  2017-04-06       Impact factor: 4.398

6.  Diffuse osteosclerosis in a patient with prostate cancer.

Authors:  N Ustün; I Ustün; T Ozgür; N Atci; F Aydoğan; A T Sümbül; A D Turhanoğlu
Journal:  Osteoporos Int       Date:  2013-10-18       Impact factor: 4.507

Review 7.  Non-endemic skeletal fluorosis: Causes and associated secondary hyperparathyroidism (case report and literature review).

Authors:  Fiona J Cook; Maighan Seagrove-Guffey; Steven Mumm; Deborah J Veis; William H McAlister; Vinieth N Bijanki; Deborah Wenkert; Michael P Whyte
Journal:  Bone       Date:  2021-01-06       Impact factor: 4.398

8.  Coexistence of two sclerotic bone diseases manifesting as spondyloarthropathy: Double trouble.

Authors:  Sanjay Kumar Bhadada; Soham Mukherjee; Prem Kumar; Anil Bhansali
Journal:  Bone Rep       Date:  2015-05-15

9.  Predictors and Outcomes Associated With Adherence to Weekly Alendronate in US Military Veterans: Clinical Research Study.

Authors:  Sarah Bou Malham; Benjamin Bowe; Sumon K Sen; Rong Mei Zhang; Barbara Sterkel; Julia P Dunn
Journal:  J Prim Care Community Health       Date:  2019 Jan-Dec

Review 10.  Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management.

Authors:  Celia L Gregson; Sarah A Hardcastle; Cyrus Cooper; Jonathan H Tobias
Journal:  Rheumatology (Oxford)       Date:  2013-02-27       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.